The tech giant's Damo Academy secured a "breakthrough device" designation from the US regulator for its pancreatic cancer-detecting AI model, Damo Panda Alibaba Group Holding's research arm, Damo ...

The FDA will remove industry representatives from advisory committees and replace them with patients and caregivers ...

Mass layoffs at the Department of Health and Human Services are continuing as the agency makes good on its intention, ...

This article examines the legal implications of AI in healthcare, focusing on liability issues and the need for clear accountability in medical AI applications.

Public records requested under the Freedom of Information Act have helped shape health policy and keep the government ...

Simulations Plus leverages AI-driven tools to revolutionize drug discovery, cut R&D costs, and capitalize on FDA regulatory ...

The question is not whether AI will transform healthcare; it’s whether regulators can keep pace with that transformation.

FDA Commissioner Martin Makary said this move would offer newer treatments for patients quicker, while also reducing the cost of research and development. Other news includes: lab models of pain ...

FRIDAY, March 21, 2025 (HealthDay News) -- The U.S. Food and Drug Administration has launched the Chemical Contaminants Transparency Tool (CCT Tool), an online searchable database to evaluate ...

Ann Phillips, senior director of regulatory and standards at PurpleLab, joins the podcast to discuss evolving price ...

New Jersey introduced rules to increase drug price transparency in the pharmaceutical ... Without this missing piece, New Jersey’s price comparison tools are incomplete — and residents are ...

We collaborate with the world's leading lawyers to deliver news tailored for you. Sign Up for any (or all) of our 25+ Newsletters. Some states have laws and ethical rules regarding solicitation ...